MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/2050313x211036005

Медицинская библиотека · SAGE open medical case reports · 2021

Malignant pericardial effusion complicated by cardiac tamponade under atezolizumab.

Benjamin Lardinois, Jean-Charles Goeminne, Laurence Miller, Adrien Randazzo, Terry Laurent, Régis Debois

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Immune-related adverse events including cardiac toxicity are increasingly described in patients receiving immune checkpoint inhibitors. We described a malignant pericardial effusion complicated by a cardiac tamponade in an advanced non-small cell lung cancer patient who had received five infusions of atezolizumab, a PDL-1 monoclonal antibody, in combination with cabozantinib. The definitive diagnosis was quickly made by cytology examination showing typical cell abnormalities and high fluorescence cell information provided by the hematology analyzer. The administration of atezolizumab and cabozantinib was temporarily discontinued due to cardiogenic hepatic failure following cardiac tamponade. After the re-initiation of the treatment, pericardial effusion relapsed. In this patient, the analysis of the pericardial fluid led to the final diagnosis of pericardial tumor progression. This was afterwards confirmed by the finding of proliferating intrapericardial tissue by computed tomography scan and ultrasound. This report emphasizes the value of cytology analysis performed in a hematology laboratory as an accurate and immediate tool for malignancy detection in pericardial effusions.

Для цитирования: Benjamin Lardinois, Jean-Charles Goeminne, Laurence Miller, Adrien Randazzo, Terry Laurent, Régis Debois. Malignant pericardial effusion complicated by cardiac tamponade under atezolizumab.. SAGE open medical case reports. 2021. DOI: 10.1177/2050313x211036005.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.